Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection

Human Immunology

Volumn 64, Issue 3, 2003, Pages 338-344

  Gentile, Deborah A ^a,b   Doyle, William J ^a   Zeevi, Adriana ^b   Howe Adams, Judith ^a   Kapadia, Shernaaz ^a   Trecki, Jordan ^a   Skoner, David P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Bronchiolitis; Cytokines; Genotypes; Infants; Otitis media; Pneumonia; Respiratory syncytial virus

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFANT; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; OXYGEN SATURATION; OXYGEN THERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT;

EID: 0037371080     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00827-3     Document Type: Article

References (34)

1. Eigen H: The RSV-asthma link: the emerging story. J Pediatr 135:S1, 1999.
2. Carlsen K: Childhood asthma and the environment. Pediatr Allergy Immunol 5:48, 1994.
3. Renzi P, Turgeon J, Marcotte J, Drblik S, Berube D, Gagnon MF, Spier S: Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med 159:1417, 1999.
4. Heikkinen T, Thint M, Chonmaitree T: Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 28:260, 1999.
5. Andrade M, Hoberman A, Glustein J, Paradise J, Wald E: Acute otitis media in children with bronchiolitis. Pediatrics 101:617, 1998.
6. Tsutsumi H, Takeuchi R, Ohsaki M, Seki K, Chiba S: Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression. J Leukoc Biol 66:99, 1999.
7. Raza M, Essery S, Weir D, Ogilvie M, Elton R, Blackwell C: Infection with respiratory syncytial virus and watersoluble components of cigarette smoke alter production of TNF-α and nitric oxide by human blood monocytes. FEMS Immunol Med Microbiol 24:387, 1999.
8. Noah T, Henderson F, Wortman I, Devlin R, Handy J, Koren H, Becker S: Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 171:584, 1995.
9. Matsuda K, Tsutsumi H, Okamoto Y, Chiba C: Development of IL-6 and TNF-α activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diag Lab Immunol 2:322, 1995.
10. Hornsleth A, Klug B, Nir M, Johansen J, Hansen K, Christensen L, Larsen L: Severity of respiratory syncytial virus disease related to type and genotype of virus and to cytokine values in nasopharyngeal secretions. Pediatr Infect Dis J 17:1114, 1998.
11. Hussell T, Pennycook A, Openshaw PJ: Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 31:2566, 2001.
12. Glezen WP, Taber LH, Frank AL, Kasel JA: Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 876:131, 1986.
13. Mira J, Cariou A, Grall F, Delclaux C: Association of TNF2, a TNF-α promoter polymorphism, with septic shock and susceptibility to mortality. JAMA 282:561, 1999.
14. Fishman D, Faulds G, Jeffrey R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the IL-6 gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369, 1999.
15. Sankaran D, Asderakis A, Ashraf S, Roberts I, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV: Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56:281, 1999.
16. Michaels MG, Serdy C, Barbadora K, Green M, Apalsch A, Wald E: Respiratory syncytial virus: a comparison of diagnostic modalities. Pediatr Infect Dis J 11:613, 1992.
17. The IMPACT-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from RSV infection in high-risk infants. Pediatrics 102:531, 1998.
18. The PREVENT Study Group: Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99:93, 1997.
19. Groothuis JR, Simoes EAF, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC: Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 329:1524, 1993.
20. Awad RA, Webber S, Boyle G, Sturchioc C, Ahmed M, Martell J, Law Y, Miller SA, Bowman P, Gribar S, Pigula F, Mazariegos G, Griffith BP, Zeevi A: The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 20:265, 2001.
21. Gentile D, Doyle W, Whiteside T, Fireman P, Hayden F, Skoner D: Increased IL-6 levels in nasal lavages following experimental influenza A infection. Clin Diag Lab Immunol 5:604, 1998.
22. Skoner D, Gentile D, Patel A, Doyle W: Evidence for cytokine mediation of symptoms in adults experimentally infected with influenza A virus. J Infect Dis 180:10, 1999.
23. Gentile DA, Patel A, Angelini BL, Doyle W, Fireman P, Skoner DP. Upper airway effects of experimental infection with respiratory syncytial virus in adult subjects. J Allergy Clin Immunol 107:S227, 2001.
24. Noah TL, Becker S: Chemokines in nasal secretions of adults experimentally infected with respiratory syncytial virus. Clin Immunol 97:43, 2000.
25. van Schaik SM, Tristman DA, Nagpal IS, Hintz KM, Welliver RC 2nd, Welliver RC: Increased production of IFN-γ and cysceinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 103:63, 1999.
26. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JM, Pekelharing-Berghuis M, van Diemen-Steenvoorde RA, Kimpen JL: Local interferon-γ levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 184:355, 2001.
27. Doyle WJ, Alper CM, Buchman C, Bergeron Y, Beauchamp D, Bergeron MG: Illness and otological change provoked by experimental upper respiratory virus infection. Laryngoscope 109:324, 1999.
28. Casselbrant ML, Mandel EM, Fall PA, Rockette HE, Kurs-Lasky M, Bluestone CD, Ferrell RE: The heritability of otitis media: a twin and triplet study. JAMA 282:2167, 1999.
29. Kvaerner KJ, Tambs K, Harris JR, Magnus P: Distribution and heritability of recurrent ear infections. Ann Otol Rhinol Laryngol 106:624, 1997.
30. Gentile DA, Yokitis J, Angelini BL, Doyle WJ, Skoner DP: Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and non-allergic patients. Ann Allergy Asthma Immunol 86:531, 2001.
31. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S: Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 97:1288, 1996.
32. Wang E, Simard M, Ouellet N, Moody SA. Skoner DP, Cohen S: Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. J Infect Dis 182:1255, 2000.
33. Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke GJ, Chen L, DeKruyff RH, Yonetsu DT: CD4 (+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest 105:61, 2000.
34. Hull J, Thomson A, Kwiatkowski D: Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55:1023, 2000.